cigna tirzepatide coverage to offer $200 Wegovy, Zepbound weight-loss benefit Cigna dropping all GLP-1 coverage

Below is a clear, realistic breakdown of how fast you can lose weight on tirzepatide, what affects your results, and whats considered normal

The MHRA has issued repeated safety alerts about the risks of purchasing unlicensed injectable peptides including GLP-1 receptor agonists and weight-loss injections from unregulated online sources, citing concerns about: Uncertain purity and potency of preparations not manufactured under GMP conditions Absence of validated stability data , including reconstituted shelf life and beyond-use dates Risk of microbial contamination in preparations made outside licensed aseptic facilities Mislabelling, adulteration, or counterfeit products sold through unregulated channels NICE guidance on pharmacotherapy for obesity currently covers licensed agents only

they are medications for treating obesity and diabetes, which have been studied in numerous large-scale clinical trials worldwide

In addition, it can be difficult to combine all of the factors, such as health risks, employee retention and culture, to get the full ROI picture

The MHRA approved it in June 2026 as the first oral GLP-1 medicine licensed in the UK for weight management, offering a needle-free alternative to the Wegovy injection